Company / PP&E per Share
Eloxx Pharmaceuticals, Inc. PP&E per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.00 / $0.10
FY2021-FY2025
Trend
+125.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share returned to growth in FY2025 after 2 years of decline, reaching $0.01.
Based on SEC 10-K filings.
0.01 in FY2025 with a 10-year CAGR of -1.9%.
Declined from $0.01 to $0.01 over the past 10 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -1.9%
Key checks
Key Insights
- In FY2025, pp&e per share increased 125.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +125.6% |
| FY2016 | $0.00 | -63.2% |
| FY2015 | $0.01 | -86.3% |
| FY2014 | $0.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026